All articles by Linda Stewart – Page 144
-
NewsNovo Nordisk Foundation partners with CARB-X to fight drug-resistant infections
The Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this ...
-
NewsNaturally occurring pathogenic fungi recruited to control Eucalyptus snout beetle
Scientists have found naturally occurring pathogenic fungi infecting the Eucalyptus snout beetle in Eucalyptus forest plantations, and characterised them to develop a bio-pesticide for controlling the beetle.
-
NewsScientists reveal why chicken farms are a breeding ground for AMR bacteria
Scientists are one step closer to understanding how bacteria, such as E. coli and Salmonella enterica, share genetic material which makes them resistant to antibiotics.
-
NewsMore than 30 new species of bacteria discovered in patient samples
A team that has been collecting and analyzing patient samples containing unknown germs since 2014 have discovered more than 30 new species of bacteria, some of which are associated with clinically relevant infections.
-
![RW703786[46]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/4/2/2/5422_rw70378646_994081.jpg)
NewsFA Bio secures £5.3m investment from Clean Growth Fund, Pymwymic and Ship2B Ventures
FA Bio, the British bio-tech company, has secured a £5.3 million tranche of investment from three European venture capital investment funds as well as existing shareholders and new private investors.
-
NewsSmart skin bacteria able to secrete and produce molecules to treat acne
An experimental study has shown that a type of skin bacterium can efficiently be engineered to produce a protein to regulate sebum production.
-
NewsBioExcel-CV19 offers breakthrough in understanding COVID-19 proteins
Designed to meet the urgent need for insights into the molecular intricacies of SARS-CoV-2 infection, BioExcel-CV19 is a repository for Molecular Dynamics (MD) simulations.
-
NewsIntravaginal sponge can make candidiasis treatment more comfortable and effective
A biodegradable sponge made of chitosan, a biopolymer derived from the shells of crustaceans, releases medication slowly into the organism and makes treatment of candidiasis more comfortable and effective.
-
NewsResearchers uncover how molecular freight elevators work in pathogenic bacteria
Researchers studying bacterial membrane transporters have studied the interaction between the transporter and its soluble substrate binding protein, showing that they adapt precisely to each other during the transportation process.
-
NewsGut bacteria combinations protect stem cell transplantation patients from dangerous immune reactions
Researchers have shown that graft versus host disease (GvHD) is less common when certain microbes are present in the gut. In the future, it may be possible to deliberately bring about this protective composition of the microbiome.
-
NewsNew AI tool accurately detects COVID-19 from chest X-rays
Researchers have developed a groundbreaking Artificial Intelligence (AI) system that can rapidly detect COVID-19 from chest X-rays with more than 98% accuracy.
-
NewsResearchers decode the ‘cytokine storm’ in sepsis
The team found that three cytokine pairs were responsible for most of the body’s damaging response to sepsis.
-
NewsCOVID-19 vaccine strongly effective for children and adolescents during delta and omicron
Children and adolescents who received one of the main COVID-19 vaccines were significantly protected and showed no increased signs of cardiac complications compared to young people who were not vaccinated.
-
NewsResearchers discover molecular ‘barcode’ used by bacteria to secrete toxins
Researchers have discovered a molecular “barcode” system used by disease-causing bacteria to distinguish between beneficial and toxic molecules.
-
NewsSARS-CoV-2 BA.2.86 less resistant to vaccine, but may be a problem in the lung
New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood.
-
NewsOldest thylakoids in fossil cyanobacteria uncover evolution of photosynthesis
Researchers have identified microstructures in fossil cells that are 1.75 billion years old. These structures, called thylakoid membranes, are the oldest ever discovered.
-
NewsResearchers unmask an old foe’s tricks to thwart new diseases
Researchers are studying Yersinia pestis, the bacterium that causes bubonic and pneumonic plague, to better understand its ability to evade the immune system and apply that understanding to control other pathogens.
-
NewsNew approach could address antibiotic resistance to Mycobacterium abscessus
Scientists have designed new versions of the drug spectinomycin that overcome efflux, the main mechanism driving resistance.
-
NewsAfrican One Health network launched to prevent disease
A new network aims to create the conditions for improved sustainable and locally led management of antimicrobial resistance and neglected tropical diseases in seven countries in sub-Saharan Africa.
-
NewsSoil fungi may help explain the global gradient in forest diversity
Mycorrhizal fungi appear to be counteracting the effects of harmful soil pathogens in ways that influence global patterns of forest diversity.